The combined vaccine elicited higher immune response against SARS-CoV-2.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Though it's an observational study and can't prove cause and effect, it holds promise.
The findings may be related to living and working conditions and other factors.
"You've got to stick with this or your health system won't be able to cope."
While younger adults with no underlying health conditions have been considered safer from COVID-19's severe outcomes, of those who were hospitalized, 22% were admitted to intensive care units (ICUs), 10% needed mechanical ventilation, and 0.6% (3 patients) died, reports a study published yesterday in Clinical Infectious Diseases.
Strategies for a secure drug supply chain discussed at National Academies public workshop.
Neither remdesivir, hydroxychloroquine, lopinavir, nor interferon-beta-1a—prevented death or other serious outcomes.
CDC Director Redfeld says the next few months will be "the most difficult in the public health history of this country."
About 30% of both pediatric and adult household contacts tested positive for COVID-19.
The vast majority of Europeans remain susceptible to surges in cases, a WHO official says.
A Sri Lankan analysis of global COVID-19 intervention measures showed that increased testing had the greatest impact on transmission: a 10-fold increase in the ratio of tests to new cases (TCR) reduced a country's average transmission by 9%. The study authors suggest that intense testing combined with isolation may be the most effective and least costly strategy for controlling COVID-19.
